An analysis of 8478 people of 20 to 59 years of age showed that current cannabis use was associated with a lower risk of metabolic syndrome, researcher of the University of Miami Leonard M. Miller School of Medicine, USA, reported. Participants completed the 2005-2010 National Health and Nutrition Examination Surveys. Metabolic syndrome was defined as 3 or more of the following: elevated fasting glucose, high triglycerides, low HDL cholesterol, elevated systolic/diastolic blood pressure, and increased waist circumference.
Fourteen percent (13.8%) of current cannabis users and 17.5% of past cannabis users presented with metabolic syndrome, compared with 19.5% of never users. Among young adults, current cannabis users were 54% less likely than never users to present with metabolic syndrome. Authors concluded that “current marijuana use is associated with lower odds of metabolic syndrome across emerging and middle-aged US adults.” Metabolic syndrome is associated with increased risk for developing diabetes, heart attack and stroke.
Vidot DC, Prado G, Hlaing WM, Florez HJ, Arheart KL, Messiah SE. Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Med. 2015 Nov 5. [in press]